Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds BTIG Downgrades Magenta Therapeutics to Neutral

BTIG Downgrades Magenta Therapeutics to Neutral

BTIG analyst Yun Zhong downgrades Magenta Therapeutics (NASDAQ:MGTA) from Buy to Neutral.

byBenzinga Newsdesk

January 26, 2023

1 minute read

BTIG analyst Yun Zhong downgrades Magenta Therapeutics (NASDAQ:MGTA) from Buy to Neutral.

Amazon Introduces New Initiative To Resolve Supply Chain Crisis

By Anusuya Lahiri

September 1, 7:24 AM

Amazon.com Inc (NASDAQ:AMZN) launched Amazon Warehousing & Distribution to help its sellers store bulk inventory and ease distribution to tackle supply…

AMZN

What’s Going On With Etsy Stock Thursday?

By Adam Eckert

November 2, 10:29 AM

Etsy Inc (NASDAQ: ETSY) shares are trading lower Thursday on the heels of the company's third-quarter results.

ETSY

Lightbridge Q2 EPS $(0.14) Up From $(0.27) YoY

By Benzinga Newsdesk

July 27, 4:36 PM

Lightbridge (NASDAQ:LTBR) reported quarterly losses of $(0.14) per share. This is a 48.15 percent increase over losses of $(0.27) per share from the same period last year.

LTBR